Painkiller addiction rise leads to increase in deaths

By Admin
Deaths related to an addiction to prescription drugs, particularly painkillers like Vicodin, now surpass that of HIV, skin cancer and alcohol-related l...

Deaths related to an addiction to prescription drugs, particularly painkillers like Vicodin, now surpass that of HIV, skin cancer and alcohol-related live disease in the US, researchers are saying.

Authors of the study, which has been published in the British Medical Journal, believe the deaths could be linked to doctors prescribing such painkillers to treat conditions like osteoporosis and not just cancer, for which they are commonly used.

Health experts are now calling for urgent action to tackle the issue, after the number of deaths caused by painkillers increased from approximately 4,000 in 1999 to over 14,000 in 2007.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Although these figures relate to the US, it is thought almost two million Germans are thought to be addicted to painkillers and there are concerns the UK could face a similar situation.

That’s after a separate study carried out by the National Treatment Agency for Substance Abuse,revealed GPs in the UK were prescribing opioid analgesics increased from 228 million in 1991 to almost 1.4 billion in 2009.

The authors of this ‘Addiction to Medicines’ study said: “The use of strong opioids for chronic non-cancer pain has been described as a “disaster in the making.”

Experts believe the increasingly popular online pharmacies could be facilitating the trend as they do not require a doctor’s prescription.

Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain